Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W R Ballou

Showing results (61-70 of 91) with videos related to

Pageof 10
Sort By:
Science (New York, N.Y.)|May 24, 1985
Immunogenicity of synthetic peptides from circumsporozoite protein of Plasmodium falciparumW R Ballou, J Rothbard, R A Wirtz, et al.
Lancet (London, England)|September 14, 1996
Randomised double-blind placebo-controlled trial of SPf66 malaria vaccine in children in northwestern Thailand. Shoklo SPf66 Malaria Vaccine Trial GroupF Nosten, C Luxemburger, D E Kyle, et al.
Science (New York, N.Y.)|June 2, 1989
Sporozoite vaccine induces genetically restricted T cell elimination of malaria from hepatocytesS L Hoffman, D Isenbarger, G W Long, et al.
Science (New York, N.Y.)|April 24, 1987
Efficacy of murine malaria sporozoite vaccines: implications for human vaccine developmentJ E Egan, J L Weber, W R Ballou, et al.
Science (New York, N.Y.)|April 15, 1988
Oral Salmonella typhimurium vaccine expressing circumsporozoite protein protects against malariaJ C Sadoff, W R Ballou, L S Baron, et al.
The American Journal of Tropical Medicine and Hygiene|May 1, 1989
Immunization of Saimiri sciureus boliviensis with recombinant vaccines based on the circumsporozoite protein of Plasmodium vivaxW E Collins, R S Nussenzweig, W R Ballou, et al.
Science (New York, N.Y.)|May 24, 1985
Expression of Plasmodium falciparum circumsporozoite proteins in Escherichia coli for potential use in a human malaria vaccineJ F Young, W T Hockmeyer, M Gross, et al.
Lancet (London, England)|June 6, 1987
Safety and efficacy of a recombinant DNA Plasmodium falciparum sporozoite vaccineW R Ballou, S L Hoffman, J A Sherwood, et al.
The American Journal of Tropical Medicine and Hygiene|November 1, 1987
Use of synthetic and recombinant peptides in the study of host-parasite interactions in the malariasG H Campbell, S B Aley, W R Ballou, et al.
Vaccine|December 1, 1989
Immunogenicity of liposomal malaria sporozoite antigen in monkeys: adjuvant effects of aluminium hydroxide and non-pyrogenic liposomal lipid AR L Richards, G M Swartz, C Schultz, et al.
Pageof 10

Showing results (61-70 of 91) with videos related to

Sort By:
Pageof 10
Science (New York, N.Y.)|May 24, 1985
Immunogenicity of synthetic peptides from circumsporozoite protein of Plasmodium falciparumW R Ballou, J Rothbard, R A Wirtz, et al.
Lancet (London, England)|September 14, 1996
Randomised double-blind placebo-controlled trial of SPf66 malaria vaccine in children in northwestern Thailand. Shoklo SPf66 Malaria Vaccine Trial GroupF Nosten, C Luxemburger, D E Kyle, et al.
Science (New York, N.Y.)|June 2, 1989
Sporozoite vaccine induces genetically restricted T cell elimination of malaria from hepatocytesS L Hoffman, D Isenbarger, G W Long, et al.
Science (New York, N.Y.)|April 24, 1987
Efficacy of murine malaria sporozoite vaccines: implications for human vaccine developmentJ E Egan, J L Weber, W R Ballou, et al.
Science (New York, N.Y.)|April 15, 1988
Oral Salmonella typhimurium vaccine expressing circumsporozoite protein protects against malariaJ C Sadoff, W R Ballou, L S Baron, et al.
The American Journal of Tropical Medicine and Hygiene|May 1, 1989
Immunization of Saimiri sciureus boliviensis with recombinant vaccines based on the circumsporozoite protein of Plasmodium vivaxW E Collins, R S Nussenzweig, W R Ballou, et al.
Science (New York, N.Y.)|May 24, 1985
Expression of Plasmodium falciparum circumsporozoite proteins in Escherichia coli for potential use in a human malaria vaccineJ F Young, W T Hockmeyer, M Gross, et al.
Lancet (London, England)|June 6, 1987
Safety and efficacy of a recombinant DNA Plasmodium falciparum sporozoite vaccineW R Ballou, S L Hoffman, J A Sherwood, et al.
The American Journal of Tropical Medicine and Hygiene|November 1, 1987
Use of synthetic and recombinant peptides in the study of host-parasite interactions in the malariasG H Campbell, S B Aley, W R Ballou, et al.
Vaccine|December 1, 1989
Immunogenicity of liposomal malaria sporozoite antigen in monkeys: adjuvant effects of aluminium hydroxide and non-pyrogenic liposomal lipid AR L Richards, G M Swartz, C Schultz, et al.
Pageof 10